Amneal Pharmaceuticals Inc (AMRX) Down -0.43% From Its 52-Week High, But Growth Potential Is Changing Over Time

Amneal Pharmaceuticals Inc (NASDAQ:AMRX) currently has a daily average trading volume of 1.65M but it saw 1080298 shares traded in last market. With a market cap of 2.12B USD, the company’s current market price of $6.87 came rising about 0.29 while comparing to the previous closing price of $6.85. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.90 and as low as $1.89.

Taking a look at 20-day trading activity of Amneal Pharmaceuticals Inc (AMRX) gives us an average price of $6.19, while its current price level is -0.43% below from 52-week high level whereas it is 263.49% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $5.93 while that of 200 days or SMA-200 reads an average of $4.98. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.32% during that period while stretching the period over a month that increases to 4.55%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 68.88 which implies that the stock is in neutral territory.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the RBC Capital Mkts which resumed the stock as “Sector Perform” in its note to investors issued on April 07, 2021, recommending a price target of $5 for it. Goldman upgraded its recommendation for the stock as a “Buy” from “Sell” on March 08, 2021 while assigning a price target range of $4-$6.50. Guggenheim issued its recommendations for the stock as it upgraded the price target for the stock is $5.50.

Over the week, AMRX’s stock price is moving 4.25% up while it is 26.06% when we observe its performance for the past one month. Year-to-date it is 13.18% up and over the past year, the stock is showing an upside performance of 240.10%.

The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of 0.19 beat the consensus estimate of 0.11 for the same. In next quarter, company is expected to be making quarterly sales of $665.82M as analysts are expecting the sales for current fiscal year at $2.66B and seeing the company making $2.76B in sales next year. Moreover, analysts are in estimates of $663.56M for current-quarter revenue.

Currently, Amneal Pharmaceuticals Inc’s total number of outstanding shares is 306.56M. Company’s return on investment (ROI) stands at -6.88% and return on equity (ROE) at -146.19%. It has a 10.13 of forward P/E ratio. Stock’s beta reads 1.20. Stock has a price to book (P/B) ratio of 106.48 while price to sale or P/S ratio amounts to 0.85. Its return on asset (ROA) is -4.76% on average.